Display options
Share it on
Full text links
Atypon Free PMC Article

J Virol. 1985 Jul;55(1):79-85. doi: 10.1128/JVI.55.1.79-85.1985.

Truncated gag-related proteins are produced by large deletion mutants of Rous sarcoma virus and form virus particles.

Journal of virology

S L Voynow, J M Coffin

PMID: 2989562 PMCID: PMC254900 DOI: 10.1128/JVI.55.1.79-85.1985
Free PMC Article

Abstract

Large deletion (LD) mutants of Prague strain Rous sarcoma virus subgroup B (PrB), derived by serial undiluted passage through chicken (C/E) cells, contain two deletions relative to wild-type virus. One of these joins gag sequences in the p12 coding region to env sequences in region encoding gp37; the other deletion spans the src region. Analysis of the viral proteins of QT6 cell clones containing only LD proviruses by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a major truncated gag-related phosphoprotein of 60,000 to 66,000 daltons (P63LD). P63LD was stable, but could be cleaved in vitro to the predicted products by p15gag. A second gag-related LD protein of about 68,000 to 74,000 molecular weight (P70LD) was also found which often reacted with an anti-gp37 serum. P70LD was unstable and may represent a short-lived gag-gp37 fusion protein. Finally, immunoprecipitation indicated that particles containing P63LD were shed from QT6-LD clones. Thin section preparations of these clones viewed in an electron microscope showed enveloped budding particles of "immature" morphology. Thus, the synthesis and release of particles from infected cells does not require cleavage of the gag precursor, nor does it require the presence of p15 or (most of) p12.

References

  1. Mol Cell Biol. 1982 Jun;2(6):638-52 - PubMed
  2. J Virol. 1972 Apr;9(4):684-97 - PubMed
  3. Virology. 1972 Aug;49(2):345-58 - PubMed
  4. J Virol. 1972 Nov;10(5):1010-20 - PubMed
  5. Virology. 1973 Dec;56(2):549-64 - PubMed
  6. J Virol. 1974 Feb;13(2):513-28 - PubMed
  7. Cold Spring Harb Symp Quant Biol. 1975;39 Pt 2:827-34 - PubMed
  8. J Virol. 1976 Mar;17(3):1063-7 - PubMed
  9. Cell. 1977 Jan;10(1):91-9 - PubMed
  10. Cell. 1977 May;11(1):95-103 - PubMed
  11. Contemp Top Immunobiol. 1977;6:127-67 - PubMed
  12. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3446-50 - PubMed
  13. Virology. 1977 Oct 15;82(2):431-48 - PubMed
  14. Virology. 1978 Jan;84(1):19-31 - PubMed
  15. Cell. 1978 May;14(1):89-104 - PubMed
  16. J Gen Virol. 1978 Jul;40(1):151-60 - PubMed
  17. J Virol. 1978 Oct;28(1):106-18 - PubMed
  18. Cell. 1978 Oct;15(2):607-14 - PubMed
  19. Virology. 1979 Jan 15;92(1):31-45 - PubMed
  20. Virology. 1979 Feb;93(1):269-74 - PubMed
  21. J Virol. 1979 Aug;31(2):420-5 - PubMed
  22. Virology. 1979 Oct 15;98(1):154-67 - PubMed
  23. Virology. 1979 Nov;99(1):103-10 - PubMed
  24. J Mol Biol. 1979 Jul 15;131(4):819-37 - PubMed
  25. J Virol. 1979 Dec;32(3):749-61 - PubMed
  26. Virology. 1980 Jan 15;100(1):130-40 - PubMed
  27. J Virol. 1980 Jan;33(1):238-49 - PubMed
  28. Virology. 1980 Apr 15;102(1):205-10 - PubMed
  29. J Virol. 1980 Oct;36(1):62-78 - PubMed
  30. Ann N Y Acad Sci. 1980;354:410-25 - PubMed
  31. J Virol. 1982 Nov;44(2):725-30 - PubMed
  32. Cell. 1983 Mar;32(3):853-69 - PubMed
  33. Virology. 1983 Apr 15;126(1):403-7 - PubMed
  34. Mol Cell Biol. 1983 Oct;3(10):1746-58 - PubMed
  35. J Mol Biol. 1984 Apr 5;174(2):297-317 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources